{"id":"https://openalex.org/W7225090769","doi":"https://doi.org/10.5281/zenodo.23890126","title":"Centrally Acting Agents: ADMET Fundamentals, Blood-Brain Barrier Penetration, and Their Role in Clinical Pharmacokinetics and Toxicology","display_name":"Centrally Acting Agents: ADMET Fundamentals, Blood-Brain Barrier Penetration, and Their Role in Clinical Pharmacokinetics and Toxicology","publication_year":2026,"publication_date":"2026-11-02","ids":{"openalex":"https://openalex.org/W7225090769","doi":"https://doi.org/10.5281/zenodo.23890126"},"language":"en","primary_location":{"id":"doi:10.5281/zenodo.23890126","doi":"https://doi.org/10.5281/zenodo.23890126","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23890126","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.5281/zenodo.23890126","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5128207978","display_name":"Peivand Pirouzi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I61412661","display_name":"Seneca Polytechnic","ror":"https://ror.org/04qgh9k98","country_code":"CA","type":"education","lineage":["https://openalex.org/I61412661"]}],"countries":["CA"],"is_corresponding":true,"raw_author_name":"Pirouzi, Peivand","raw_affiliation_strings":["College of Professional Studies, Northeastern University, Toronto, ON, Canada","School of Health Sciences, Seneca Polytechnic, Toronto, ON, Canada","Crown College of Canada, Toronto, ON, Canada"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"College of Professional Studies, Northeastern University, Toronto, ON, Canada","institution_ids":[]},{"raw_affiliation_string":"School of Health Sciences, Seneca Polytechnic, Toronto, ON, Canada","institution_ids":["https://openalex.org/I61412661"]},{"raw_affiliation_string":"Crown College of Canada, Toronto, ON, Canada","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5128207978"],"corresponding_institution_ids":["https://openalex.org/I61412661"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.79336219,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.7979000210762024,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11872","display_name":"Barrier Structure and Function Studies","score":0.7979000210762024,"subfield":{"id":"https://openalex.org/subfields/2808","display_name":"Neurology"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.16740000247955322,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.00800000037997961,"subfield":{"id":"https://openalex.org/subfields/3002","display_name":"Drug Discovery"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/blood-brain-barrier-penetration","display_name":"blood-brain barrier penetration","score":0.9649999737739563},{"id":"https://openalex.org/keywords/central-nervous-system-distribution","display_name":"central nervous system distribution","score":0.8240000009536743},{"id":"https://openalex.org/keywords/p-glycoprotein-efflux","display_name":"P-glycoprotein efflux","score":0.8619999885559082},{"id":"https://openalex.org/keywords/cerebrospinal-fluid","display_name":"cerebrospinal fluid","score":0.8640000224113464},{"id":"https://openalex.org/keywords/microdialysis","display_name":"microdialysis","score":0.9369999766349792},{"id":"https://openalex.org/keywords/clinical-pharmacokinetics","display_name":"clinical pharmacokinetics","score":0.8500000238418579},{"id":"https://openalex.org/keywords/drug-toxicity","display_name":"drug toxicity","score":0.5730000138282776},{"id":"https://openalex.org/keywords/regulatory-toxicology","display_name":"regulatory toxicology","score":0.4860000014305115}],"concepts":[{"id":"https://openalex.org/C529278444","wikidata":"https://www.wikidata.org/wiki/Q47273","display_name":"Central nervous system","level":2,"score":0.6983000040054321},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6664999723434448},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.6279000043869019},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6021000146865845},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5386999845504761},{"id":"https://openalex.org/C2778402981","wikidata":"https://www.wikidata.org/wiki/Q221694","display_name":"Blood\u2013brain barrier","level":3,"score":0.4797999858856201},{"id":"https://openalex.org/C63433958","wikidata":"https://www.wikidata.org/wiki/Q1774688","display_name":"Clinical pharmacology","level":2,"score":0.4081000089645386},{"id":"https://openalex.org/C169760540","wikidata":"https://www.wikidata.org/wiki/Q207011","display_name":"Neuroscience","level":1,"score":0.37689998745918274},{"id":"https://openalex.org/C128188215","wikidata":"https://www.wikidata.org/wiki/Q3026765","display_name":"Neuropharmacology","level":2,"score":0.37540000677108765},{"id":"https://openalex.org/C2776190711","wikidata":"https://www.wikidata.org/wiki/Q7398663","display_name":"Safety pharmacology","level":3,"score":0.3614000082015991},{"id":"https://openalex.org/C2779446555","wikidata":"https://www.wikidata.org/wiki/Q7663877","display_name":"Systems pharmacology","level":3,"score":0.32690000534057617},{"id":"https://openalex.org/C545706735","wikidata":"https://www.wikidata.org/wiki/Q9404","display_name":"Nervous system","level":2,"score":0.29649999737739563},{"id":"https://openalex.org/C74187038","wikidata":"https://www.wikidata.org/wiki/Q1418791","display_name":"Drug discovery","level":2,"score":0.2669000029563904},{"id":"https://openalex.org/C2910715078","wikidata":"https://www.wikidata.org/wiki/Q162657","display_name":"Neurotransmitter Agents","level":4,"score":0.2619999945163727},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.2605000138282776},{"id":"https://openalex.org/C2987276129","wikidata":"https://www.wikidata.org/wiki/Q12140","display_name":"Drug administration","level":2,"score":0.2597000002861023},{"id":"https://openalex.org/C545314008","wikidata":"https://www.wikidata.org/wiki/Q169953","display_name":"Peripheral nervous system","level":3,"score":0.25609999895095825}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.5281/zenodo.23890126","doi":"https://doi.org/10.5281/zenodo.23890126","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23890126","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"},{"id":"doi:10.5281/zenodo.23890127","doi":"https://doi.org/10.5281/zenodo.23890127","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23890127","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"}],"best_oa_location":{"id":"doi:10.5281/zenodo.23890126","doi":"https://doi.org/10.5281/zenodo.23890126","is_oa":true,"landing_page_url":"https://doi.org/10.5281/zenodo.23890126","pdf_url":null,"source":{"id":"https://openalex.org/S4306400562","display_name":"Zenodo (CERN European Organization for Nuclear Research)","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I67311998","host_organization_name":"European Organization for Nuclear Research","host_organization_lineage":["https://openalex.org/I67311998"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"article-journal"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9537000060081482,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2000285669","https://openalex.org/W2005447377","https://openalex.org/W4414561839","https://openalex.org/W2409935314","https://openalex.org/W4285223654","https://openalex.org/W2762493662","https://openalex.org/W2112893277","https://openalex.org/W2030028063","https://openalex.org/W177396578","https://openalex.org/W2006669174"],"abstract_inverted_index":{"Centrally":[0],"acting":[1,43,77,108],"agents,":[2],"drugs":[3],"whose":[4],"intended":[5],"pharmacological":[6],"target":[7],"resides":[8],"within":[9],"the":[10,16,50,58,71,80],"central":[11,67,88,113],"nervous":[12,68,114],"system,":[13],"must":[14],"cross":[15],"blood-brain":[17,63,111],"barrier":[18,64],"in":[19],"sufficient":[20],"quantity":[21],"to":[22,54,61,75],"achieve":[23],"a":[24,29,41,106],"therapeutically":[25],"relevant":[26],"brain":[27],"concentration,":[28],"requirement":[30],"that":[31],"imposes":[32],"distinctive":[33],"physicochemical":[34],"and":[35,66,79,101],"transporter-related":[36],"constraints":[37],"not":[38],"present":[39],"for":[40,98],"peripherally":[42],"drug":[44,56,91,109],"(Pardridge,":[45],"2005).":[46],"This":[47],"article":[48,94],"examines":[49],"ADMET":[51],"fundamentals":[52],"specific":[53,74],"this":[55],"category,":[57],"assays":[59],"used":[60],"characterize":[62],"penetration":[65],"system":[69,115],"distribution,":[70],"toxicology":[72],"considerations":[73],"centrally":[76,107],"mechanisms,":[78],"clinical":[81,102],"pharmacokinetic":[82],"study":[83],"design":[84],"implications":[85],"of":[86],"distinguishing":[87],"from":[89],"peripheral":[90],"exposure.":[92],"The":[93],"closes":[95],"with":[96],"recommendations":[97],"regulatory":[99,125],"affairs":[100],"pharmacology":[103],"professionals":[104],"developing":[105],"program.Keywords:":[110],"barrier;":[112],"penetration;":[116],"P-glycoprotein":[117],"efflux;":[118],"cerebrospinal":[119],"fluid;":[120],"microdialysis;":[121],"unbound":[122],"brain-to-plasma":[123],"ratio;":[124],"artificial":[126],"intelligence":[127]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-11-03T00:00:00"}